UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$257M |
| 2 |
Microsoft
MSFT
|
+$214M |
| 3 |
Meta Platforms (Facebook)
META
|
+$212M |
| 4 |
Palo Alto Networks
PANW
|
+$180M |
| 5 |
Alibaba
BABA
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$224M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$212M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$156M |
| 4 |
Eli Lilly
LLY
|
+$123M |
| 5 |
Fortinet
FTNT
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.21% |
| 2 | Healthcare | 13.78% |
| 3 | Financials | 13.47% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Communication Services | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.84B
| $2.7M | ﹤0.01% |
80,893
+21,569
| +36% | +$732K |
|
1352
The GEO Group
GEO
$4.04B
| $2.68M | ﹤0.01% |
139,592
+10,424
| +8% | +$224K |
|
1353
FB Financial Corp
FBK
$3.04B
| $2.68M | ﹤0.01% |
84,298
-1,386
| -2% | -$47.9K |
|
|
ELLI
1354
DELISTED
Ellie Mae Inc
ELLI
| $2.67M | ﹤0.01% |
27,052
+4,709
| +21% | +$409K |
|
|
VRN
1355
DELISTED
Veren
VRN
| $2.66M | ﹤0.01% |
821,515
-6,986
| -0.8% | -$21.5K |
|
1356
Sinclair Inc
SBGI
$1.03B
| $2.66M | ﹤0.01% |
69,128
+11,204
| +19% | +$375K |
|
1357
Core Laboratories
CLB
$521M
| $2.66M | ﹤0.01% |
38,582
-4,376
| -10% | -$293K |
|
1358
Visteon
VC
$2.78B
| $2.65M | ﹤0.01% |
39,382
+5,523
| +16% | +$416K |
|
1359
Northwest Natural Holdings
NWN
$2.12B
| $2.64M | ﹤0.01% |
40,194
+923
| +2% | +$57.9K |
|
1360
Omnicell
OMCL
$1.68B
| $2.64M | ﹤0.01% |
32,624
+3,316
| +11% | +$248K |
|
1361
CNX Resources
CNX
$5.2B
| $2.63M | ﹤0.01% |
244,131
+18,523
| +8% | +$209K |
|
1362
Tandem Diabetes Care
TNDM
$1.56B
| $2.61M | ﹤0.01% |
41,160
+3,137
| +8% | +$165K |
|
|
HTZ
1363
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $2.6M | ﹤0.01% |
172,567
-11,884
| -6% | -$173K |
|
1364
Emergent Biosolutions
EBS
$248M
| $2.59M | ﹤0.01% |
51,346
+1,569
| +3% | +$92.5K |
|
1365
Antero Resources
AR
$10.7B
| $2.59M | ﹤0.01% |
293,244
-425,955
| -59% | -$4.02M |
|
1366
Tetra Tech
TTEK
$9.07B
| $2.57M | ﹤0.01% |
215,750
-194,860
| -47% | -$2.18M |
|
|
IRBT
1367
DELISTED
iRobot
IRBT
| $2.57M | ﹤0.01% |
21,848
+2,293
| +12% | +$244K |
|
1368
John Wiley & Sons Class A
WLY
$2.66B
| $2.57M | ﹤0.01% |
58,136
+8,070
| +16% | +$396K |
|
1369
JetBlue
JBLU
$2.29B
| $2.57M | ﹤0.01% |
157,065
+22,481
| +17% | +$385K |
|
1370
Unifirst Corp
UNF
$5.25B
| $2.57M | ﹤0.01% |
16,722
-181
| -1% | -$25.4K |
|
1371
WisdomTree US SmallCap Earnings Fund
EES
$731M
| $2.56M | ﹤0.01% |
70,890
| – | – |
|
1372
BOK Financial
BOKF
$8.74B
| $2.55M | ﹤0.01% |
31,318
+9,698
| +45% | +$815K |
|
1373
Churchill Downs
CHDN
$6.12B
| $2.55M | ﹤0.01% |
56,522
+2,384
| +4% | +$106K |
|
1374
Sally Beauty Holdings
SBH
$1.58B
| $2.55M | ﹤0.01% |
138,459
+2,600
| +2% | +$46.4K |
|
|
SYNH
1375
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.54M | ﹤0.01% |
49,105
+7,142
| +17% | +$346K |
|
Similar funds
UBS AM's Q1 2019 Portfolio in Review
As of Q1 2019, UBS AM held 2,870 positions worth $135B, up 16% from $116B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q1 2019 filing shows 103 new, 1,731 increased, 679 reduced and 79 closed positions. Its largest new stake was Fox Class A: 1,047,931 shares worth $38.5M. The largest sale was PepsiCo, an estimated $224M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2019 buy was Fox Class A: 1,047,931 shares worth $38.5M.
- UBS AM added most to Procter & Gamble in Q1 2019, an estimated $257M increase.
- UBS AM's biggest Q1 2019 reduction was PepsiCo, cutting an estimated $224M.
- UBS AM fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $156M.
- UBS AM's ten largest holdings make up 19% of its $135B portfolio in Q1 2019.
- UBS AM opened 103 new positions and closed 79 in Q1 2019.
- UBS AM's portfolio value rose 16% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.